PMV Pharmaceuticals share price logo

PMV Pharmaceuticals

NASDAQ: PMVP

$1.27

-0.05

(-3.77%)

as on

PMV Pharmaceuticals Stock Performance

as on November 6, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.20
    $1.29
    downward going graph

    5.51%

    Downside

    1.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.02
    $1.91
    downward going graph

    19.69%

    Downside

    50.39%

    Upside

    downward going graph

PMV Pharmaceuticals share price movements today

Previous Close
$1.32
Open
$1.28
Volume
773.0K
Market Cap
$104.2M
Day's Low - High
$1.20 - $1.29
52 Week Low - High
$1.02 - $1.91

PMV Pharmaceuticals Historical Returns

1 Month Return
-25.56 %
3 Month Return
+ 13.25 %
1 Year Return
+ 1.15 %
3 Year Return
-30.63 %
5 Year Return
-94.6 %

PMV Pharmaceuticals Stock Fundamentals & Key Indicators

Check PMV Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$104.2M

EPS (TTM)

-1.42

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.97

Industry PE ratio

-3.24

PEG Ratio

-0.10

EBITDA

-75.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-78.11%

PMV Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PMV Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$104.2M-94.60%-0.970.00%0.00%
Neutral$91.2B9.03%-28.63-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$99.4B52.18%20.7385.77%0.38%

Stock Returns calculator for PMV Pharmaceuticals Stock including INR - Dollar returns

The PMV Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

PMV Pharmaceuticals investment value today

Current value as on today

₹1,02,672

Returns

₹2,672

(+2.67%)

Returns from PMV Pharmaceuticals Stock

-₹3,053 (-3.05%)

Dollar Impact

₹5,726 (+5.73%)

Analyst Recommendation on PMV Pharmaceuticals Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for PMV Pharmaceuticals. Average target price of $4

PMV Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on PMV Pharmaceuticals.

What analysts predicted

68.25%UPSIDE

Target Price

$4

Current Price

$1.27

Analyzed by

1 Analysts

High

$5

Target

$4.00

Low

$5

PMV Pharmaceuticals target price $4, a slight upside of 68.25% compared to current price of $1.27. According to 1 analysts rating.

Indian Investors' Interest in PMV Pharmaceuticals Stock

Search interest for PMV Pharmaceuticals Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

PMV Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
0
-
-
0
-
Operating Income
-18
-20
-21
-25
-21
-22
-22
-19
-19
-18
EBITDA
-14
-17
-18
-22
-19
-21
-21
-17
-18
-18
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-17
-19
-23
-19
-21
-21
-18
-18
-18
Income Tax Expense
-
-16
0
-
-2
0
0
0
-
0
Net Income
-15
-1
-19
-23
-17
-21
-21
-18
-18
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PMV Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-1
0
-1
-1
-
Operating Income
-18
-26
-34
-58
-77
-80
-85
-86
EBITDA
-18
-24
-34
-57
-73
-67
-73
-79
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
1
1
0
Income Before Tax
-17
-25
-34
-57
-73
-68
-74
-79
Income Tax Expense
0
0
0
0
0
0
-16
-2
Net Income
-17
-25
-34
-57
-73
-68
-58
-77
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PMV Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-15
-1
-19
-23
-17
-21
-21
-18
-18
-18
Operating Cash Flow
-16
-1
-16
-16
-18
-18
-19
-17
-19
-14
Investing Cash Flow
26
2
17
7
28
10
12
18
20
-12
Financing Cash Flow
-
0
-
0
0
0
-
0
-
0
Change in Cash
9
0
0
-8
10
-7
-7
1
1
-26

PMV Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-25
-34
-57
-73
-68
-58
-77
Operating Cash Flow
-15
-22
-32
-46
-63
-55
-51
-73
Investing Cash Flow
21
3
27
-143
-1
-50
53
70
Financing Cash Flow
-
61
292
2
0
35
0
0
Change in Cash
6
42
288
-188
-64
-70
2
-2

Global Institutional Holdings in PMV Pharmaceuticals

Check out the Institutions with significant holdings in PMV Pharmaceuticals.

Funds
Holdings
Vanguard
3.99%
VANGUARD INDEX FUNDS
2.57%
David Henry Mack
1.49%
Meridian Fund Inc
1.40%
BlackRock, Inc.
1.22%

PMV Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 31 August

    Tue, 01:35 AM

    -

    PMV Pharmaceuticals announces completion of enrollment for Phase 2 ovarian cancer trial and plans NDA submission in Q1 2027.

    Tue, 01:35 AM

    -

    PMV Pharmaceuticals initiates underwritten public offering of common stock and warrants.

    Tue, 02:00 AM

    -

    PMV Pharmaceuticals reports promising Phase 2 ovarian cancer data with 46% overall response rate.

Insights on PMV Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PMVP stock has moved up by 8.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 235.0% return, outperforming this stock by 272.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 892.4% return, outperforming this stock by 890.4%

About PMV Pharmaceuticals

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.
OrganisationPMV Pharmaceuticals
Headquarters400 Alexander Park Drive, Princeton, NJ, 08540, US
IndustryBiotechnology
CEODavid H. Mack

Key Management of PMV Pharmaceuticals

Name

Title

Dr. David H. Mack Ph.D.

Co-Founder, CEO, President & Director

Mr. Robert Ticktin J.D.

General Counsel, COO & Company Secretary

Ms. Crystal Zuckerman

Vice President of Human Resources

Dr. Marc Fellous M.D.

Senior VP and Head of Clinical Development & Medical Affairs

Dr. Arnold J. Levine Ph.D.

Co-Founder, Independent Director & Member of Scientific Advisory Board

Dr. Deepika Jalota Pharm.D.

Chief Development Officer

Mr. Michael Carulli

CFO & Principal Financial & Accounting Officer

Mr. Tim Smith M.B.A.

Senior VP and Head of Corporate Development & Investor Relations

Mr. Steve Dyott

Vice President of Marketing

Dr. Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

FAQs

What is PMV Pharmaceuticals share price today?

PMV Pharmaceuticals share price today is $1.27 as on at the close of the market. PMV Pharmaceuticals share today touched a day high of $1.29 and a low of $1.20.

What is the 52 week high and 52 week low for PMV Pharmaceuticals share?

PMV Pharmaceuticals share touched a 52 week high of $1.91 on and a 52 week low of $1.02 on . PMV Pharmaceuticals stock price today i.e. is closed at $1.27,which is 33.51% down from its 52 week high and 24.51% up from its 52 week low.

What is PMV Pharmaceuticals's market capitalisation today?

PMV Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in PMV Pharmaceuticals Stock (PMVP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PMV Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy PMV Pharmaceuticals Stock (PMVP) from India?

Indian investors can start investing in PMV Pharmaceuticals (PMVP) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in PMV Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on PMV Pharmaceuticals share’s latest price of $1.27 as on November 6, 2026 at 8:45 am IST, you will get 7.8740 shares of PMV Pharmaceuticals. Learn more about fractional shares .

What are the returns that PMV Pharmaceuticals has given to Indian investors in the last 5 years?

PMV Pharmaceuticals stock has given -94.6% share price returns and 28.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?